Cargando…

Spiky nanostructures for virus inhibition and infection prevention

The outbreak of a novel highly infectious virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has aroused people’s concern about public health. The lack of ready-to-use vaccines and therapeutics makes the fight with these pathogens extremely difficult. To this point, rationally desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Chuanxiong, Ma, Lang, Luo, Hongrong, Bao, Jinku, Cheng, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363616/
https://www.ncbi.nlm.nih.gov/pubmed/33349812
http://dx.doi.org/10.1016/j.smaim.2020.07.004
_version_ 1783559669599436800
author Nie, Chuanxiong
Ma, Lang
Luo, Hongrong
Bao, Jinku
Cheng, Chong
author_facet Nie, Chuanxiong
Ma, Lang
Luo, Hongrong
Bao, Jinku
Cheng, Chong
author_sort Nie, Chuanxiong
collection PubMed
description The outbreak of a novel highly infectious virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has aroused people’s concern about public health. The lack of ready-to-use vaccines and therapeutics makes the fight with these pathogens extremely difficult. To this point, rationally designed virus entry inhibitors that block the viral interaction with its receptor can be novel strategies to prevent virus infection. For ideal inhibition of the virus, the virus-inhibitor interaction has to outperform the virus-host interaction. In our view, the morphology of the inhibitor should be carefully designed to benefit virus-inhibitor binding, especially that the surfaces of viruses are mostly rough due to the existence of surface proteins for receptor-binding. In this perspective article, we would like to discuss the recent progress of designing inhibitors with spiky topography to maximize the interactions between viruses and inhibitors. We also would like to share our idea for the future study of inhibitors to prevent virus infection.
format Online
Article
Text
id pubmed-7363616
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73636162020-07-16 Spiky nanostructures for virus inhibition and infection prevention Nie, Chuanxiong Ma, Lang Luo, Hongrong Bao, Jinku Cheng, Chong Smart Mater Med Original Research Article The outbreak of a novel highly infectious virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has aroused people’s concern about public health. The lack of ready-to-use vaccines and therapeutics makes the fight with these pathogens extremely difficult. To this point, rationally designed virus entry inhibitors that block the viral interaction with its receptor can be novel strategies to prevent virus infection. For ideal inhibition of the virus, the virus-inhibitor interaction has to outperform the virus-host interaction. In our view, the morphology of the inhibitor should be carefully designed to benefit virus-inhibitor binding, especially that the surfaces of viruses are mostly rough due to the existence of surface proteins for receptor-binding. In this perspective article, we would like to discuss the recent progress of designing inhibitors with spiky topography to maximize the interactions between viruses and inhibitors. We also would like to share our idea for the future study of inhibitors to prevent virus infection. The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2020 2020-07-16 /pmc/articles/PMC7363616/ /pubmed/33349812 http://dx.doi.org/10.1016/j.smaim.2020.07.004 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Research Article
Nie, Chuanxiong
Ma, Lang
Luo, Hongrong
Bao, Jinku
Cheng, Chong
Spiky nanostructures for virus inhibition and infection prevention
title Spiky nanostructures for virus inhibition and infection prevention
title_full Spiky nanostructures for virus inhibition and infection prevention
title_fullStr Spiky nanostructures for virus inhibition and infection prevention
title_full_unstemmed Spiky nanostructures for virus inhibition and infection prevention
title_short Spiky nanostructures for virus inhibition and infection prevention
title_sort spiky nanostructures for virus inhibition and infection prevention
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363616/
https://www.ncbi.nlm.nih.gov/pubmed/33349812
http://dx.doi.org/10.1016/j.smaim.2020.07.004
work_keys_str_mv AT niechuanxiong spikynanostructuresforvirusinhibitionandinfectionprevention
AT malang spikynanostructuresforvirusinhibitionandinfectionprevention
AT luohongrong spikynanostructuresforvirusinhibitionandinfectionprevention
AT baojinku spikynanostructuresforvirusinhibitionandinfectionprevention
AT chengchong spikynanostructuresforvirusinhibitionandinfectionprevention